NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/09/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization24.15 mln
Float7.61 mln
Earnings Date09/29/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.25
Reliable
Relative Strength
89
/ 100
Strongly outperforming
Debt / Equity
0.62
Moderate leverage
ROE
-135
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Aytu BioPharma is a Denver-based pharmaceutical company that develops and sells prescription medications across the United States and international markets. The company's primary focus is treating attention deficit hyperactivity disorder in children and adults through several branded drug products. It also offers a range of children's health products, including an allergy medicine and fluoride-based vitamins designed for infants and young children.
